DaVita Inc logo

DVA - DaVita Inc Share Price

$124.34 -1.1  -0.9%

Last Trade - 9:10pm

Large Cap
Market Cap £9.45bn
Enterprise Value £16.29bn
Revenue £8.18bn
Position in Universe 795th / 6846
Unlock DVA Revenue
Relative Strength (%)
1m +17.5%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -3.23%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
13,782 10,707 10,877 11,405 11,388 11,551 11,576 11,975 -3.5%
-6.2 +22.2 -27.5 +20.9 +58.1 +31.0 +21.3 +12.4
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2021, Davita Increvenues decreased 1% to $2.82B. Net income beforeextraordinary items increased 3% to $237.4M. Revenuesreflect U.S. dialysis segment decrease of 2% to $2.56B,Other—Ancillary services segment decrease of 1% to $257.1M.Basic Earnings per Share excluding Extraordinary Itemsincreased from $1.84 to $2.18.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for DVA
Graphical History


DVA Revenue Unlock DVA Revenue

Net Income

DVA Net Income Unlock DVA Revenue

Normalised EPS

DVA Normalised EPS Unlock DVA Revenue

PE Ratio Range

DVA PE Ratio Range Unlock DVA Revenue

Dividend Yield Range

DVA Dividend Yield Range Unlock DVA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
DVA EPS Forecasts Unlock DVA Revenue
Profile Summary

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.

Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated April 4, 1994
Public Since October 31, 1995
No. of Shareholders: 7,594
No. of Employees: 67,000
Sector Healthcare
Industry Healthcare Providers & Services
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 106,200,000
Free Float (0.0%)
Eligible for
DVA Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for DVA
Upcoming Events for DVA
Thursday 10th June, 2021
DaVita Inc Annual Shareholders Meeting
Friday 11th June, 2021 Estimate
DaVita Inc Annual Shareholders Meeting
Wednesday 28th July, 2021 Estimate
Q2 2021 DaVita Inc Earnings Release
Wednesday 27th October, 2021 Estimate
Q3 2021 DaVita Inc Earnings Release
Frequently Asked Questions for DaVita Inc
What is the DaVita Inc share price?

As of 9:10pm, shares in DaVita Inc are trading at $124.34, giving the company a market capitalisation of £9.45bn. This share price information is delayed by 15 minutes.

How has the DaVita Inc share price performed this year?

Shares in DaVita Inc are currently trading at $124.34 and the price has moved by 60.49% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the DaVita Inc price has moved by 11.76% over the past year.

What are the analyst and broker recommendations for DaVita Inc?

Of the analysts with advisory recommendations for DaVita Inc, there are there are currently 0 "buy" , 5 "hold" and 0 "sell" recommendations. The overall consensus recommendation for DaVita Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will DaVita Inc next release its financial results?

DaVita Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the DaVita Inc dividend yield?

DaVita Inc does not currently pay a dividend.

Does DaVita Inc pay a dividend?

DaVita Inc does not currently pay a dividend.

When does DaVita Inc next pay dividends?

DaVita Inc does not currently pay a dividend.

How do I buy DaVita Inc shares?

To buy shares in DaVita Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of DaVita Inc?

Shares in DaVita Inc are currently trading at $124.34, giving the company a market capitalisation of £9.45bn.

Where are DaVita Inc shares listed? Where are DaVita Inc shares listed?

Here are the trading details for DaVita Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: DVA
What kind of share is DaVita Inc?

Based on an overall assessment of its quality, value and momentum, DaVita Inc is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a DaVita Inc share price forecast 2021?

Shares in DaVita Inc are currently priced at $124.34. At that level they are trading at 1.36% premium to the analyst consensus target price of 0.00.

Analysts covering DaVita Inc currently have a consensus Earnings Per Share (EPS) forecast of 8.541 for the next financial year.

How can I tell whether the DaVita Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DaVita Inc. Over the past six months, the relative strength of its shares against the market has been 0.05%. At the current price of $124.34, shares in DaVita Inc are trading at 21.48% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the DaVita Inc PE Ratio?

The DaVita Inc PE ratio based on its reported earnings over the past 12 months is 17.19. The shares are currently trading at $124.34.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of DaVita Inc?

DaVita Inc's management team is headed by:

John Nehra - IND
Charles Berg - DRC
Paul Diaz - IND
Javier Rodriguez - CEO
Pamela Arway - CHM
Barbara Desoer - IND
Kathleen Waters - OTH
Joel Ackerman - CFO
James Hearty - CCO
John Winstel - CAO
Kenny Gardner - OTH
Shawn Guertin - DRC
Who are the major shareholders of DaVita Inc?

Here are the top five shareholders of DaVita Inc based on the size of their shareholding:

Berkshire Hathaway Inc. Insurance Company
Percentage owned: 33.99% (36.1m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.82% (8.30m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 3.71% (3.94m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 3.39% (3.60m shares)
LSV Asset Management Investment Advisor
Percentage owned: 2.19% (2.33m shares)
Similar to DVA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.